Lee Carter recently joined host Jason Chaffetz on the Jason in the House podcast for a conversation on “The Importance of Looking Beyond the Data.”
Lee Carter joins Jason Chaffetz on Jason in the House podcast
June 4, 2025
Author Archives: Randy Kershner
Lee Carter on CNN with Jake Tapper
June 4, 2025
Lee Carter joined CNN’s Jake Tapper for a colorful panel discussion on topics ranging from Trump’s “big beautiful bill” and Democrats’ failure to come up with a better solution… to the new Trump “TACO” acronym and more. Some fun and always-insightful analysis from Lee!
Talking Tariffs: How Companies Can Communicate Effectively in a No-Win Situation
June 3, 2025
As the Trump administration fights over the future of its tariffs in the courts, companies are anxiously considering how to deal with this massive shift in U.S. trade policy. Tariffs have already increased costs for many businesses, and they threaten the ability of some companies to survive. Many companies are asking: what’s the right language and framing to talk about tariffs in a way that protects our business without antagonizing Washington? Michael Maslansky offers some sound advice for how to respond while mitigating the risk.
Michael Maslansky on NewsNation: Democrats fail to reach their audience
May 28, 2025
How do you connect with a critical audience or constituency when you don’t have a message that resonates with them? Michael Maslansky addressed this question on NewsNation with Leland Vittert, for an interesting conversation on how the Democratic party has failed to reach and connect with young white men.
The Pharma Dilemma: Trust, Pricing, and the New Language of Fairness
May 15, 2025
In this episode of Hearsay, Lee Carter is joined by partners Keith Yazmir and Katie Cronen to unpack why communicating effectively—especially in industries like pharma—is harder than ever.
Navigating Pharma Pricing: A Constructive Response to Executive Orders
May 12, 2025
President Trump’s executive order on pharmaceutical pricing is a wake-up call. For pharma companies, the question is not whether or not to react—but how. And how pharma companies react will have a big impact on where this debate ends. Reframe the narrative right and they have a unique opportunity to shift the conversation and become champions of both innovation and accessibility. Here’s thoughtful guidance for a constructive response.
Communicating in the Age of Rage
April 25, 2025
It’s a chaotic time in America. Trust is shattered. People are angry. From DEI and tariffs, to rising prices, excessive profits, and broken promises, people on the left and the right believe our system is broken—and that dramatic change needs to happen. And business is getting the brunt of it. Companies need to respond to shift the conversation in their favor. In this eye-opening piece, Lee Carter shares how it’s time for a new way forward, with actionable insights to help you thrive in this new environment.
Lee Carter on CNN News Central: Low approval ratings among Independents
April 21, 2025
Lee Carter joins CNN to talk about the lowest approval rating among independents for President Trump’s handling of the economy.
Inside Voice: How Companies Are Navigating DEI Internally
April 17, 2025
In this episode, Michael Maslansky, Lee Carter, and special guest Michelle Mahony from Daggerwing, dive into the evolving role of language in business, with a special focus on internal communications and DEI.
Companies are Afraid to Talk About Climate Action. They Shouldn’t Be.
April 16, 2025
Sustainability leaders at some of the world’s largest companies are scared. They feel there’s no safe way to communicate about climate and environmental issues in today’s supercharged political environment. Michael Maslansky argues otherwise in this provocative piece. Instead of avoiding the issue, retreating from past positions, or scaling back communications, he believes there’s a real opportunity right now for companies to be environmentally responsible—if they get their message right.